← Back to Search

Resilience Intervention for Aging (ARIAA-2 Trial)

N/A

Waitlist Available

Led By Emily Bartley, PhD

Research Sponsored by University of Florida

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 8 weeks

Awards & highlights

ARIAA-2 Trial Summary

This trial will test whether a resilience intervention can help chronic low back pain sufferers among older adults.

Eligible Conditions

Aging
Chronic Lower Back Pain

ARIAA-2 Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 8 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~8 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Enrollment rate

Home activity feasibility

Percentage of enrolled participant retention

+5 more

ARIAA-2 Trial Design

1Treatment groups

Experimental Treatment

Group I: Resilience InterventionExperimental Treatment1 Intervention

Participants will initially complete a baseline assessment assessing study eligibility. The Resilience intervention consists of seven weekly 1.5-hour group sessions guided by trained clinicians. Due to the COVID-19 pandemic, these group session may be conducted through Zoom. Skills and content will be directed toward improving pain management by enhancing positive emotions, setting goals, learning to live a life according to one's values, and boosting self-confidence in one's ability to manage pain. Self-administered activities include the identification of personal strengths, pleasant activity scheduling, expressing gratitude, values clarification, mindfulness practice, goal setting, positive reappraisal, and noting positive events.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Resilience Intervention

2020

N/A

~60

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Institute on Aging (NIA)NIH

1,671 Previous Clinical Trials

28,017,004 Total Patients Enrolled

160 Trials studying Aging

75,948 Patients Enrolled for Aging

University of FloridaLead Sponsor

1,340 Previous Clinical Trials

715,646 Total Patients Enrolled

28 Trials studying Aging

3,343 Patients Enrolled for Aging

Emily Bartley, PhDPrincipal InvestigatorUniversity of Florida

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is registration still open for this experiment?

"This clinical trial is not currently accepting any new participants. It was initially posted on January 21st 2020, and the last update occurred September 14th 2022. However, other trials are still actively enrolling patients; at present there are 580 such studies open for recruitment."

Answered by AI